A simple paper test could offer early cancer diagnosis
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
Two-component system could offer a new way to halt internal bleeding
The technology, which mimics the body’s natural clotting process, could help keep severely injured people alive until they are treated at a hospital.
Vaccine printer could help vaccines reach more people
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
Nanoparticles provoke immune response against tumors but avoid side effects
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
Recycling plastics from research labs
With sustainability in mind, MIT’s EHS Lab Plastics Recycling Program gathers clean plastics from 212 MIT labs, recycling some 280 pounds per week.
Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies
The global health care company Sanofi is providing $25 million to advance RNA research.
New nanoparticles can perform gene editing in the lungs
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
A novel combination therapy for treating vancomycin-resistant bacterial infections
Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.
STEAM power on the runway
Boston teen designers create fashion inspired by award-winning images from MIT laboratories.
Why lung cancer doesn’t respond well to immunotherapy
A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.
Targeting cancer with a multidrug nanoparticle
Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.
MIT researchers develop an AI model that can detect future lung cancer risk
Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.
Compassion in the details
The late MIT Professor Angelika Amon was recognized as Committed to Caring for her generous and encompassing mentorship.
Enzyme “atlas” helps researchers decipher cellular pathways
Biologists have mapped out more than 300 protein kinases and their targets, which they hope could yield new leads for cancer drugs.
Portraiture at the intersection of art, science, and society
Exhibit at MIT's Koch Institute attempts to make visible the luminary personalities behind major scientific and engineering advances.